Advanced search

Enhancement of tamoxifen-induced E-cadherin function by Ca2+ channel antagonists in human breast cancer MCF7/6 cells.

(1996) EUROPEAN JOURNAL OF PHARMACOLOGY. 317(2-3). p.413-416
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
CHARLIER, C, Erik Bruyneel, C LECHANTEUR, Marc Bracke, Marcus Mareel, and V CASTRONOVO. 1996. “Enhancement of Tamoxifen-induced E-cadherin Function by Ca2+ Channel Antagonists in Human Breast Cancer MCF7/6 Cells.” European Journal of Pharmacology 317 (2-3): 413–416.
APA
CHARLIER, C., Bruyneel, E., LECHANTEUR, C., Bracke, M., Mareel, M., & CASTRONOVO, V. (1996). Enhancement of tamoxifen-induced E-cadherin function by Ca2+ channel antagonists in human breast cancer MCF7/6 cells. EUROPEAN JOURNAL OF PHARMACOLOGY, 317(2-3), 413–416.
Vancouver
1.
CHARLIER C, Bruyneel E, LECHANTEUR C, Bracke M, Mareel M, CASTRONOVO V. Enhancement of tamoxifen-induced E-cadherin function by Ca2+ channel antagonists in human breast cancer MCF7/6 cells. EUROPEAN JOURNAL OF PHARMACOLOGY. 1996;317(2-3):413–6.
MLA
CHARLIER, C, Erik Bruyneel, C LECHANTEUR, et al. “Enhancement of Tamoxifen-induced E-cadherin Function by Ca2+ Channel Antagonists in Human Breast Cancer MCF7/6 Cells.” EUROPEAN JOURNAL OF PHARMACOLOGY 317.2-3 (1996): 413–416. Print.
@article{151399,
  author       = {CHARLIER, C and Bruyneel, Erik and LECHANTEUR, C and Bracke, Marc and Mareel, Marcus and CASTRONOVO, V},
  issn         = {0014-2999},
  journal      = {EUROPEAN JOURNAL OF PHARMACOLOGY},
  language     = {eng},
  number       = {2-3},
  pages        = {413--416},
  title        = {Enhancement of tamoxifen-induced E-cadherin function by Ca2+ channel antagonists in human breast cancer MCF7/6 cells.},
  volume       = {317},
  year         = {1996},
}